We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Filters

Equity Crowdfunding Pitches

Showing results
Her.9 is a Direct-To-Consumer (DTC) female technology brand that caters to the needs of women during pregnancy. It cites research arguing that up to 40% of women taking prenatal vitamins may not be able to absorb the folic acid within the UK’s leading pregnancy brand. Her.9 aims to resolve this by employing DUOCAP technology. The company asserts that DUOCAP is a capsule-in-capsule delivery system which contains solubilised prebiotics in the outer capsule and probiotics in the inner capsule. The prebiotic releases immediately and the probiotic releases later allowing for targeted supplement delivery in the body. The prenatal supplements market is set to be worth $56 billion globally by 2024. Her.9 aims to be a notable contender in this segment. The company is raising investment to build its already established partnerships and execute its marketing strategy effectively.

Pitch Rated

50%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £215,946
Charm is a peer-to-peer impact investment platform that allows a user to use his/her investments to drive positive change in the world while earning a financial return. Morgan Stanley estimates that 85% of people are interested in sustainable investing. Charm enables individuals to fund projects led by high-impact entrepreneurs selling clean energy solutions in developing economies. Users can view their investments on the company's transparent, personalised impact investment dashboard, as well as, earn social, environmental and financial bottom line returns for their contributions. The company secured a £496,000 grant funding to develop its platform, refine its offering & provide growth capital. It is in the process of becoming an appointed representative of a Financial Conduct Authority (FCA) authorised entity post this funding round. It will use the investment to expand its team, develop its platform, and raise brand awareness.

Pitch Rated

82%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £273,720
StanMe aims to be the first community marketplace to enable collaboration and co-selling between independent creators. It asserts that the majority of creators have to continuously learn techniques to market themselves, adapt to social platforms’ ever-changing algorithms, and grow and maintain a large community to generate a sufficient amount of sales. StanMe claims that not all can do so and intends to address this situation with its services. It launched its public beta in July 2020 with more than 1,000 users and has processed over 130 transactions since its beta launch. StanMe claims it has more than 1,900 pre-registered users on its waiting list and aspires to become a contender in the creator economy valued at $11 billion in 2019. It will use the investment to accelerate its growth, invest in technology, and boost marketing initiatives.

Pitch Rated

69%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £164,080
TellJO is a company that comes with a mission to help 25M people of the UK who are susceptible to vulnerability. The company's TrustTech platform 'TellJO digital' is an intermediary between businesses and their vulnerable customers. TellJO has been utilised by 3 companies, and it is supported by Bethnal Green Ventures. The company is looking forward to developing "Team TellJO" that will help it achieve sustainable but rapid growth. With the proceeds, the company is looking forward to scaling its 1st to the market solution and develop the TellJO team.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £82,290
EMERGEiQ is a cloud-based platform targeted towards Small and Medium Enterprises (SMEs) and large corporate organisations. The company plans on having an extensive suite of algorithms that simplifies Data Science (DS) and Artificial Intelligence (AI) at low cost, across all sectors. EMERGEiQ asserts that its analytics can help businesses improve operational productivity, cut costs, and eventually generate more revenue. It has worked with companies across a variety of sectors such as finance, medicine, stock market, and insurance. The company will use will 30% of the investment for R&D, 25% to purchase software and hardware to improve platform capabilities, 25% to market its new product line, 10% as working capital, and 10% as miscellaneous expenses.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £150,000
miiCARE is a MedTech specialising in AI applied to geriatrics (elderly care). Its key product miiCUBE offers cutting-edge home-based and customised healthcare, helping the elderly enjoy their independence while being comprehensively connected to their families, friends, and neighbours. The company aims to provide these benefits to one billion people by 2028, comprising older people, family members and carers. Till date, miiCARE has secured partnerships with the UK’s largest NHS trust, Ebbsfleet Garden City, O2, Bristol Careline and Microsoft, and won multiple social impacts and digital health awards during the last 12 months. Funds raised will be used mainly for fulfilling pre-orders and close interests for large contracts with corporates, marketing and logistics, product development, sales and salaries.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £103,672
Anastasis Biotec (AB) is a company that is developing a human protein-based product, Syntana-4 (S-4), that inhibits Cancer Stem Cells (CSC) - the growth engine of cancer. The global cancer drug market was at ~$200 billion in 2019. S-4 will initially target use for patients with relapsed prostate cancer which caused 3.8% of global cancer deaths in 2018. The company asserts that S-4 will have low manufacturing costs, making it affordable, enabling ‘mass-market’ sales. AB has raised £450,000 in equity convertible loans and grants in 2019 & 2020, including an Innovate-UK award. It is also aiming to progress S-4 further in collaboration with the University of Chicago’s cancer stem cell therapeutics Research and development (R&D) program. The company will use the investment to complete lab-testing before starting clinical trials.

Pitch Rated

53%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £270,543
GIBIE combines ancient Indian dying methods with modern weaving technologies to produce sustainable and luxurious homewares. The company argues that the textile industry uses an astonishing 9 trillion gallons of water annually, as well as, releases harmful gases and chemicals in the air and water. GIBIE aims to change this scenario by bringing forth sustainable linen that has superior qualities to chemically enhanced and dyed linen. It has come out with an industrial-scale production proposal of its linen. The company is a PETA-approved vegan brand and a member of the Color Ashram Foundation that promotes the usage of herbal dyes around the world. GIBIE will use the investment to launch its essential sales programs, boost marketing initiatives and scale production.

Pitch Rated

57%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £158,571
Cuckoo is an internet broadband provider. The company claims that incumbent internet providers treat customers with poor customer service, high prices, and complicated contracts. Cuckoo aims to change this by providing users with fair and transparent prices, simple contracts, high-quality routers, and responsive customer service. The company is currently developing its website and billing engine ahead of launching with its first customers in the second quarter of 2020. Cuckoo's business is in the pre-revenue stage. It expects to start generating revenue in May/June 2020 when they launch their broadband service. Cuckoo will use 50% of the investment towards paying salaries to staff, 25% as technology development fees, 10% as professional fees, 5% as rent, and 10% as AOB. Cuckoo's exit strategy is via a trade sale or listing in the United Kingdom.

Pitch Rated

71%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £69,622
eDrinks is on a mission to help the hospitality industry harness the power of technology and social media. It has come out with digital drink tokens redeemable in partner pubs and bars. Users can gift and receive the tokens from friends, family or even a stranger and redeem them in pubs and bars using the 'MyRound' app. eDrinks has acquired over 2000 users over 1.5 months through organic social marketing, of which, 1011 are active ones. It has also availed the Commercial Partner Membership (CPM) of the British Beer & Pub Association (BBPA). The company is also developing its proprietary 'Bar Tab' redemption app to make it easy for independent venues to scan and redeem eDrinks contactless. eDrinks will use the investment to create marketing campaigns, app development, and hiring personnel.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £116,195
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph